Molecular Anatomy of CCR5 Engagement by Physiologic and Viral Chemokines and HIV-1 Envelope Glycoproteins: Differences in Primary Structural Requirements for RANTES, MIP-1, and vMIP-II Binding

By Navenot J-M.   Wang Z-x.   Trent J.O.   Murray J.L.   Hu Q-x.   deLeeuw L.   Moore P.S.   Chang Y.   Peiper S.C.  

Journal of Molecular Biology, Vol. 313, Iss. 5, 2001-11 ,pp. : 1181-1193

Academic Press

Access to resources Recommend Favorite

A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population

By Xu Lidan   Qiao Yuandong   Zhang Xuelong   Sun Haiming   Wang Jingwei   Sun Donglin   Jia Xueyuan   Shen Chao   Zhao Yanling   Jin Yan   Yu Yang   Ling Hong   Wang Kaili   Fu Songbin  

Molecular Biology Reports, Vol. 38, Iss. 1, 2011-01 ,pp. : 327-332

Springer Publishing Company

Access to resources Recommend Favorite

Ionic interaction of the HIV-1 V3 domain with CCR5 and deregulation of T lymphocyte function

By Baritaki S.   Zafiropoulos A.   Sioumpara M.   Politis M.   Spandidos D.A.   Krambovitis E.  

Biochemical and Biophysical Research Communications, Vol. 298, Iss. 4, 2002-11 ,pp. : 574-580

Elsevier

Access to resources Recommend Favorite

A Synthetic Peptide Fragment Derived from RANTES is a Potent Inhibitor of HIV-1 Infectivity Despite a Surprising Lack of CCR5 Receptor Affinity

By Emabelle Ramnarine  

Letters in Peptide Science, Vol. 10, Iss. 5, 2003-01 ,pp. : 637-643

Springer Publishing Company

Access to resources Recommend Favorite

Evidence as a HIV-1 Self-Defense Vaccine of Cyclic Chimeric Dodecapeptide Warped from Undecapeptidyl Arch of Extracellular Loop 2 in Both CCR5 and CXCR4

By Misumi S.   Takamune N.   Ido Y.   Hayashi S.   Endo M.   Mukai R.   Tachibana K.   Umeda M.   Shoji S.  

Biochemical and Biophysical Research Communications, Vol. 285, Iss. 5, 2001-08 ,pp. : 1309-1316

Elsevier

Access to resources Recommend Favorite